Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. - Haffner,SM.; Greenberg,AS.; Weston,WM.; Chen,H.; Williams,K.; Freed,MI. (Circulation, 2002)